Pengbo Yu

Dr. Pengbo Yu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Environmental Pollution
Verified
Journal Article
Closed access
STSanyi Tang
Sanyi Tang
QYQinling Yan
Qinling Yan
WSWei Shi
Wei Shi
XWXia Wang
Xia Wang
XSXiaodan Sun
Xiaodan Sun
YXYanni Xiao
Yanni Xiao

29 January 2014 in Viruses
Verified
Journal Article
Open access
PDF file
CMChaofeng Ma
Chaofeng Ma
ZWZengguo Wang
Zengguo Wang
SLShen Li
Shen Li
YXYuan Xing
Yuan Xing
RWRui Wu
Rui Wu
PYPengbo Yu
Pengbo Yu
The aim of the present study was to analyze an outbreak of hemorrhagic fever with renal syndrome (HFRS), caused by a Hantavirus, in college students in the northern urban area of Xi’an in 2012. The outbreak affected six students and included two deaths. The epidemiological survey revealed that both of the deceased cases were misdiagnosed initially, and treatment was delayed. Furthermore, a higher rodent population density and lower HFRS vaccine coverage were observed in the affected area, which indicates a possible role in the outbreak. Rattus norvegicus (Rn) and Mus musculus (Mm) were the predominant host populations in the area. Genotyping revealed that all HVs from patients and rodents were Hantaan virus (HTNV). Sequence analysis of the S segments revealed that the HTNVs reported in this study had high similarity with strains reported in 2011 and 1985, but these viruses diverged from a strain isolated in 1984 and the HTNV prototype strain 76-118. Detection of anti-HV IgG and amplification of the S segment of HTNV from a non-natural HTNV reservoir indicates that further investigations by increased rodent trapping are necessary.

18 November 2024 in Nature Ecology & Evolution
Verified
Journal Article
Closed access
PDF file
SPShan Pei
Shan Pei
PYPengbo Yu
Pengbo Yu
JRJayna Raghwani
Jayna Raghwani
YWYuxin Wang
Yuxin Wang
ZLZiyan Liu
Ziyan Liu
HTHuaiyu Tian
Huaiyu Tian

15 June 2017 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
CMChaofeng Ma
Chaofeng Ma
XHXiaoyun Hao
Xiaoyun Hao
HDHuiling Deng
Huiling Deng
RWRui Wu
Rui Wu
JLJifeng Liu
Jifeng Liu
XWXiaokang Wu
Xiaokang Wu

1 January 2021 in China CDC Weekly
Verified
Journal Article
Open access
PDF file
JWJing Wei
Jing Wei
XPXi’aN Center For Disease Control And Prevention Of Shaanxi Province
Xi’aN Center For Disease Control And Prevention Of Shaanxi Province
XHXiaoxia Huang
Xiaoxia Huang
SLShen Li
Shen Li
SDShanshan Du
Shanshan Du
JLJiandong Li
Jiandong Li

8 February 2025 in Virology Journal
Verified
Journal Article
Open access
PDF file
JWJing Wei
Jing Wei
HZHui Zhang
Hui Zhang
JPJiawei Pei
Jiawei Pei
QYQiqi Yang
Qiqi Yang
YWYuan Wang
Yuan Wang
WYWei Ye
Wei Ye
Hantaan orthohantavirus (HTNV) is responsible for severe hemorrhagic fever with renal syndrome (HFRS), which has a case fatality rate of 1% to 10%. Currently, the inactive vaccine licensed in endemic areas elicit low levels of neutralizing antibodies (NAbs). Early NAbs administration is helpful for patients recovery from HFRS. Therefore, measuring NAbs is crucial for evaluating the immune response following infection or vaccination. The golden standard for HTNV NAbs measurement is the focus reduction neutralization test (FRNT), which typically requires skilled technicians and is performed under high biosafety containment facility. Here, we established a surrogate NAbs titration method with replication-competent vesicular stomatitis virus (VSV) bearing HTNV glycoprotein (rVSV-HTNV-GP) based plaque reduction neutralization test (PRNT). Then compared and correlated this method with the authentic HTNV based FRNT, and applied it to measure the NAbs level in 47 serum samples from HFRS patients, healthy donors and inactive vaccine recipients. We observed positive correlations between two neutralization assays among HFRS patients and inactive vaccine recipients (R2 = 0.5994 and 0.3440, respectively) and confirmed the clear specificity with healthy donors without vaccinated and reproducibility with three more assays. Our results suggest that rVSV-HTNV-GP based PRNT is a reliable lower-biosafety level surrogate for HTNV NAbs evaluation, which is easy to perform with higher sensitivity.